3 Things To Watch After Sandoz's Biosimilars Win
Sandoz Inc.'s triumph over Amgen Inc. in the first big court fight over key provisions of the Biologics Price Competition and Innovation Act carries major implications for a coming wave of...To view the full article, register now.
Already a subscriber? Click here to view full article